Showing results (141-150 of 2,822) with videos related to

Sort By:
Pageof 283
Cytotherapy|October 11, 2022
Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trialKarl S Peggs, Sarah J Albon, Macarena Oporto Espuelas, et al.
Cytotherapy|March 8, 2021
Soluble factors differ in platelets derived from separate niches: a pilot study comparing the secretome of peripheral blood and bone marrow plateletsRyan C Dregalla, Jessica A Herrera, Edward J Donner
Cytotherapy|March 9, 2021
Thermal conditioning improves quality and speed of keratinocyte sheet production for burn wound treatmentLaura Frese, Salim E Darwiche, Brigitte von Rechenberg, et al.
Cytotherapy|September 9, 2022
Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trialMartha L Arango-Rodríguez, Víctor Alfonso Solarte-David, Silvia M Becerra-Bayona, et al.
Cytotherapy|August 28, 2022
Stem-like memory T cells are generated during hollow fiber perfusion-based expansion and enriched after cryopreservation in an automated modular cell therapy manufacturing processAnnie W Cunningham, Mark Jones, Nathan Frank, et al.
Cytotherapy|October 24, 2022
Emerging frontiers in immuno- and gene therapy for cancerMichael P Gustafson, John A Ligon, Alexey Bersenev, et al.
Cytotherapy|July 20, 2015
Evaluation of the safety and tolerability of a high-dose intravenous infusion of allogeneic mesenchymal precursor cellsCourtney A McDonald, David Oehme, Yen Pham, et al.
Cytotherapy|July 4, 2015
Autologous adipose-derived stem cells attenuate muscular atrophy and protect spinal cord ventral horn motor neurons in an animal model of burn injurySheng-Hua Wu, Shu-Hung Huang, Yi-Ching Lo, et al.
Cytotherapy|August 10, 2021
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulinRutvij A Khanolkar, Amit Kalra, Megan Kinzel, et al.
Cytotherapy|May 16, 2021
The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacyZhe Kang Law, Hui Jan Tan, Sze Piaw Chin, et al.
Pageof 283